Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Pediatric Hematology
How long do you continue to follow children with now resolved autoimmune hemolytic anemia in hematology clinic to monitor for recurrence or secondary conditions?
Related Questions
How would you counsel a woman with a strong family history of thrombosis about oral contraceptives?
If a pediatric patient has a prior history of cancer-associated thrombosis while receiving active treatment, can they be on estrogen-containing OCPs in the future?
How do you choose between therapies for newly diagnosed ITP that is refractory to steroids and IVIG?
What is your preferred treatment for refractory warm autoimmune hemolytic anemia with autoimmune neutropenia?
What experience have you had with familial clustering of polycythemia vera?
How do you counsel patients with acute intermittent porphyria when it comes to fasting for religious reasons?
What is the best way to prepare children with von Willebrand disease for tonsillectomy to reduce risk of post-operative hemorrhage?
Does continuous platelet transfusion reduce platelet refractoriness in ECMO?
What workup needs to be performed on pediatric patients with warm autoimmune hemolytic anemia prior to initiation of treatment with immunosuppressants?
For pediatric severe aplastic anemia, is an alemtuzumab (campath) based conditioning regimen preferred over ATG?
